SpringWorks Therapeutics (NASDAQ:SWTX) Receives $52.57 Consensus Target Price from Brokerages
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) has earned a consensus recommendation of “Hold” from the eight research firms that are currently covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price target among brokers […]
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) has earned a consensus recommendation of “Hold” from the eight research firms that are currently covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price target among brokers […]
